CASR and neonatal severe primary hyperparathyroidism: <h4>Background</h4>Loss-of-function variants in the calcium-sensing receptor (<i>CASR</i>) gene are known to be involved in a clinical spectrum ranging from asymptomatic familial hypocalciuric hypercalcemia (FHH) to neonatal severe hyperparathyroidism (NSHPT).